Estrogen and progesterone combined in OCs act in a synergistic manner in the gonadotropin axis. They decrease the secretion of hypophysial-luteinizing hormone and follicle-stimulating hormone by ...

While IL-23 inhibitors, which include guselkumab, tildrakizumab, and risankizumab, are currently FDA-approved solely for the treatment of psoriasis, several other inflammatory skin conditions have ...

Content Baylor College of Medicine offers one training position per year in our Micrographic Surgery and Dermatologic Oncology fellowship, approved by the Accreditation Council for Graduate Medical ...